Digistain

Breast cancer recurrence-risk testing for clinicians treating eligible patients after surgery

Newport Pagnell, United KingdomFounded 2019digistain.co.ukWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Digistain

Digistain provides a quantitative histopathology test that uses optical spectral imaging and a validated statistical model to generate recurrence-risk information for breast cancer patients after surgery. The test runs on routine FFPE tissue sections and supports, but does not replace, clinical judgement.

The test is intended for professional use for invasive breast cancer patients with Stage I–II, HER2-negative, ER-positive disease and up to three positive lymph nodes. Digistain states that results are returned within 1–2 days of specimen receipt at its UK laboratory.

Digistain Limited was founded in 2019 and is headquartered in Newport Pagnell, United Kingdom. Its technology was developed by cancer researchers and physicists from Imperial College London.

Product: A quantitative histopathology test that uses optical spectral imaging and statistical modelling to provide breast cancer recurrence-risk information.

Jobs at Digistain

No open positions listed right now.

Leadership

More health & medtech companies

  • Digital Care AI

    Cloud care management software for UK care providers, covering care plans, visit monitoring and CQC and Ofsted compliance reporting
    London, United KingdomHealth & medtechFounded 2022
    Young company
  • Digital Prosthetics

    Digital dental laboratory producing crowns, implant prostheses and dentures for dental practices
    Birmingham, United KingdomHealth & medtechFounded 2020
    New on Evolc
  • Digostics

    Home oral glucose tolerance testing platforms for healthcare providers screening patients for diabetes
    Didcot, United KingdomHealth & medtechFounded 2019
    New on Evolc
  • Diligram

    Governance software for healthcare organisations to manage policies, training, acknowledgements and audit evidence
    London, United KingdomHealth & medtechFounded 2020
  • Diphex Solutions

    Chemical first-aid products and training for workplaces handling hazardous chemicals across the UK
    Maidstone, United KingdomHealth & medtechFounded 20211 open job
    New on EvolcRemote-friendly
  • Direct Healthcare Group

    Medical devices and care services for healthcare providers supporting people with reduced movement
    Caerphilly, United KingdomHealth & medtechFounded 2004

All health & medtech companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Marketing & advertising

  • LinkedIn InsightMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.